KRX/006280 (KRX/006280)

Korea Stock Exchange: KRX/006280 · KRW

₩130,500

+1394.34 (+1.1%)· Recorded snapshot

Market cap	1.5T
Revenue (ttm)	2T
Net income (ttm)	-49.9B
EPS (ttm)	-₩4,372
Shares out	11.4M
P/E (forward)	7.0x
Dividend	₩1,500 (1.15%)
Volume	13,570
Beta	0.68

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2T
Net income (ttm): -49.9B
EPS (ttm): -₩4,372
P/E (forward): 7.0x
Market cap: 1.5T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E7

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-4.5

P25 n/aP50 n/aP75 n/a

ROIC2.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All KRX/006280 indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

KRW

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	South Korea
Country code	KR
Earnings date	2026-11-13
Employees	2,111
Enterprise value	KRW 2.5T
Exchange	Korea Stock Exchange
Financial currency	KRW
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1967
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	KR7006280002
Last earnings date	2025-11-14
Last refreshed	2026-10-28
Last stock split date	2013-06-07
Last stock split type	Forward
Market cap	KRW 1.5T
Next earnings date	2026-11-13
Price	KRW 130,500.00
Price currency	KRW
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	krx/006280
Website	https://www.gcbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	71.78x
Earnings yield	-3.35%
EV/EBIT	29.76x
EV/EBITDA	14.66x
EV/FCF	28.18x
EV/Sales	1.26x
FCF / EV yield	3.55%
FCF yield	5.89%
Forward P/E	6.96x
Industry forward P/E	13.69x
Industry P/E	18.5x
P/B ratio	1.12x
P/FCF ratio	16.97x
P/OCF ratio	8.08x
P/S ratio	0.76x
Price / tangible book value	1.65x
Price/EBITDA ratio	11.21x
Sector forward P/E	24.78x
Sector P/E	49.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.41%
EBITDA margin	6.76%
FCF margin	4.47%
Gross margin	26.32%
Operating margin	2.41%
Pretax margin	-2.96%
Profit margin	-2.54%
Profit per employee	KRW -23.6M
Profitable quarters	2
Revenue per employee	KRW 930.3M
ROA	1%
ROA (5Y)	1.41%
ROCE	2.62%
ROE	-4.54%
ROE (5Y)	1.65%
ROIC	2.15%
ROIC (5Y)	2.53%
Tax / revenue	0.27%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	-94.78%
EPS growth (QoQ)	-90.31%
EPS growth years	2
Gross profit growth	-3.1%
Gross profit growth (Q)	-29.48%
Gross profit growth 3Y	-1.02%
Gross profit growth 5Y	2.54%
Net income growth (Q)	-94.78%
Net income growth (QoQ)	-90.31%
Net income growth years	2
OCF growth 3Y	54.51%
OCF growth 5Y	19.21%
Operating income growth	-25.43%
Operating income growth (Q)	-93.35%
Operating income growth 3Y	9.59%
Operating income growth 5Y	1.17%
Revenue growth	9.73%
Revenue growth (Q)	-15.81%
Revenue growth (QoQ)	-3.3%
Revenue growth 10Y	5.83%
Revenue growth 3Y	5.9%
Revenue growth 5Y	5.45%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -96.5B
Depreciation and amortization	KRW 85.6B
EBIT	KRW 47.3B
EBITDA	KRW 132.8B
EPS	KRW -4,372.28
FCF per share	KRW 7,690.02
Financing cash flow	KRW -136.7B
Free cash flow	KRW 87.8B
Gross profit	KRW 517B
Income taxes	KRW 5.3B
Investing cash flow	KRW -98.3B
Net borrowing	KRW -117.1B
Net cash flow	KRW -42.5B
Net income	KRW -49.9B
Operating income	KRW 47.3B
Revenue	KRW 2T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.93
Book value per share	KRW 108,356.51
Debt / EBITDA	7.07
Debt / equity	0.71
Debt / FCF	10.7
Interest coverage	0.93
Long-term assets	KRW 1.5T
Long-term liabilities	KRW 481.8B
Net cash (debt)	KRW -894.2B
Net cash / market cap	-60.04%
Net debt / EBITDA	6.73
Net debt / equity	0.67
Net debt / FCF	10.19
Piotroski F-Score	5
Property, plant and equipment	KRW 883.3B
Shareholders' equity	KRW 1.3T
Tangible book value	KRW 905B
Tangible book value per share	KRW 79,295.48
Total assets	KRW 2.8T
Total cash	KRW 44.7B
Total debt	KRW 938.8B
Total liabilities	KRW 1.5T
WACC	6.57%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	KRW 1.3T
Current liabilities	KRW 1T
Current ratio	1.3
Inventory turnover	1.63
Net working capital	KRW 795.2B
Quick ratio	0.4
Working capital	KRW 305.5B
Working capital turnover	7.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	0%
Dividend growth (10Y)	-1.53%
Dividend growth (3Y)	-5.01%
Dividend growth (5Y)	0%
Dividend growth years	0
Dividend payment date	2026-04-21
Dividend payment years	1
Dividend payout frequency	Annual
Dividend per share	KRW 1,500.00
Dividend yield	1.15%
Ex-dividend date	2026-03-30
FCF payout ratio	19.51%
Last dividend	KRW 1,500.00
Shareholder yield	1.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-11.82%
10Y return CAGR	-0.4%
10Y total return	-3.92%
150-day SMA	KRW 130,779.33
15Y price change	-20.33%
15Y return CAGR	-0.48%
15Y total return	-6.98%
1D price change	1.08%
1M price change	5.84%
1M total return	5.84%
1W price change	-1.66%
1W total return	-1.66%
1Y price change	-1.66%
1Y return CAGR	-0.67%
1Y total return	-0.67%
20-day SMA	KRW 128,570.00
200-day SMA	KRW 138,503.00
20Y price change	170.8%
20Y return CAGR	6.32%
20Y total return	240.42%
3M price change	5.41%
3M total return	5.41%
3Y price change	34.81%
3Y return CAGR	11.61%
3Y total return	39.05%
50-day SMA	KRW 127,170.00
50-day SMA vs 200-day SMA	50under200
52-week high	KRW 183,800.00
52-week high date	2026-02-12
52-week low	KRW 105,900.00
52-week low date	2026-08-03
5Y price change	-51.21%
5Y return CAGR	-12.45%
5Y total return	-48.57%
6M price change	-7.84%
6M total return	-7.84%
All-time high	KRW 654,761.91
All-time high date	1995-01-04
All-time low	KRW 4,857.14
All-time low date	2003-03-17
Average true range (ATR)	KRW 4,501.42
Average volume	20.8K
Beta (1Y)	0.46
Beta (2Y)	0.64
Beta (5Y)	0.68
Change from 52-week high	-29%
Change from 52-week low	23.23%
Change from all-time high	-80.07%
Change from all-time low	2,586.76%
Change from open	1.08%
Day's gap	0%
Dollar volume	KRW 1.8B
High price	KRW 132,700.00
Low price	KRW 129,000.00
Monthly RSI	47.78
Open price	KRW 129,100.00
Position in 52-week range	40.54%
Previous close	KRW 129,100.00
Price vs 150-day SMA	-0.21%
Price vs 20-day SMA	1.5%
Price vs 200-day SMA	-5.78%
Price vs 50-day SMA	2.62%
Relative volume	0.66
RSI	54.93
Sharpe ratio	0.18
Sharpe ratio (3Y)	0.24
Sharpe ratio (5Y)	-0.37
Sortino ratio	0.39
Sortino ratio (3Y)	0.5
Sortino ratio (5Y)	-0.38
Volume	13.6K
Weekly RSI	49.1
YTD price change	-17.92%
YTD total return	-17.1%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.5M
Shares change (QoQ)	0%
Shares change (YoY)	0%
Shares held by insiders	0.94%
Shares held by institutions	14.28%
Shares outstanding	11.4M

Deeper analysis on KRX/006280

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this KRX/006280 report

Is a complete KRX/006280 research report available?

No complete published report is available for krx/006280 (KRX/006280) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

KRX/006280 (KRX/006280)

Price

Financial snapshot

Fair-value bridge

Latest news · KRX/006280

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KRX/006280 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on KRX/006280

Frequently asked questions